Together with Stephen Fry, Colin McFarlane, David Cameron, Steve McQueen, Jeremy Clarkson and Nick Jones, I’ve written to the Health Secretary about prostate cancer.
Prostate cancer is now the most common cancer among men in Britain. It kills one man every 45 minutes, many after a diagnosis too late for treatment to succeed. Black men face a 1 in 4 lifetime risk, double that of the general population, and men whose fathers or brothers have had the disease face a similar threat.
In May the National Screening Committee refused to extend screening beyond a group of just 1,500 men with one specific genetic variant. Everyone else at high risk doesn't have guaranteed access to a test that could save their life. We believe that's wrong, and that the Secretary of State has both the evidence and the power to overturn the ruling.
More than 250 MPs from across the political spectrum have called for a targeted national screening programme, and over 100,000 people have signed petition demanding the same. A programme targeted at those at highest risk would cost £25 million a year, which is 0.01% of the NHS budget.
We are asking the Secretary of State to reconsider the Committee's recommendation and commit to a targeted national screening programme; to act now, rather than wait a decade for further trial data while men continue to die; and to ensure that risk, not luck, decides who is tested.
🏆Amazing achievement by the whole team and all our partners in sites across the UK.
🙏🏽Thank you all.
🔀🔀IP7-PACIFIC is a double RCT comparing prostate bpMRI to mpMRI, and visual / cognitive targeting to image fusion targeting
📶 700 to go
Funded by @CR_UK@SU2C@SU2CUK
There's more than Will Rogers to consider. PSMA-PET depicts a different disease state. @piet_ost There is also asymmetric utility in rule-in and rule-out for randomising (Rx escalation) @IP_London@declangmurphy@DrMHofman only a randomised study like AVIDITY will satisfy all 🙏
@LondonProstate1@ProfPadhani@ProstateUKProfs Tried to set up such a trial but most colleagues did not want to randomise… So we did it differently and randomised the treatment: SOC vs escalated therapy based on PET/Decipher in Thunder.
📣The £42M TRANSFORM study will get a £20M boost so that all eligible Black men are invited to join stage 2
📶Policies on healthcare for any group to be based on evidence
🇬🇧Govt also funding wider access to focal prostate therapy to ⬇️ harms of surgery & radiotherapy
A sharper way to assess prostate cancer risk is here.
Pi™ now delivers an integrated risk score combining MRI AI, PSA and PIRADS®. Published evidence shows ~20% fewer unnecessary biopsies with maintained csPCa detection.
Full announcement: https://t.co/vZrfKcHCAc
🚨 New in Eur Urol Oncol: Key Performance Metrics (KPMs) to fairly measure benefits & harms of prostate cancer diagnostics (MRI + biopsy avoidance)!
Explainer video 👇
https://t.co/lyAnW8BFRU
Full article: https://t.co/zvZ1wIeT2O
#ProstateCancer#MRI@ProfPadhani@EurUrolOncol
Because you wouldn’t let it slide… these are rolling out today for our most requested feature:
Prompt-Based Revisions: Tweak, tailor, and tune your slides just by prompting the revisions you want
PPTX Support: You can now export your Slide Decks (Google Slides coming next!)
I scraped every single NotebookLM prompt that blew up on X, Reddit, and academic corners of the internet.
Turns out most people are using NotebookLM like a fancy note-taker.
That's insane.
It's a full-blown research assistant that can compress 10 hours of analysis into 20 seconds if you feed it the right instructions.
Here's what actually works:
🚨 Special ACORE Expert Webinar 🚨
We are honored to host Prof. Anwar Padhani, one of the world’s foremost authorities in oncologic MRI.
Join us for a high-impact, must-attend session on:
Whole-body MRI in opportunistic cancer diagnosis: Dos and Don’ts
A rare opportunity to learn directly from a global leader shaping modern cancer imaging.
📅 Thursday, January 29 | ⏰ 12:00 PM CST
🎓 This is not just a webinar — it’s a masterclass.
Register here: [https://t.co/dMxgqljVHL]
#ACORE #Radiology #MRI #WholeBodyMRI #CancerImaging #OncologicImaging #RadiologyEducation #RadEdu #MedTwitter #ImagingExperts
Thrilled beyond words to share that I've been informed of my promotion to Professor of Radiology! Endless gratitude to my leadership, mentors, colleagues, residents/students, family, and patients most of all.
Also, huge congratulations to amazing friends @sportsraddoc, @AmitGupta_83, and Yong Chen on their well-deserved promotions.
Onward! 🚀
@UHRadiology@UH_RadiCLE@UH_RE_Institute
The UK National Screening Committee has decided there isn't enough evidence to recommend screening for the vast majority of men.
But it's not the end.
Our Director of Research, Dr Matthew Hobbs, explains more ⤵️
#ProstateCancer l #MensHealth l #Screening
Part 2: AI-targeted review
AI flags all suspicious lesions on MRI. Radiologists verify each region and double-check negatives. This boosts detection, streamlines reporting, and reduces variability.
Full paper: https://t.co/YrYISzlbmf
@ProfPadhani